Our results were also consistent with clinical observations in T1DM patients, showing that the subgroup with microvascular diseases had substantially severer bone loss than the subgroup without microvascular diseases despite similar glycemic control and insulin dosage 7, 8. This evidence concerns the gene INS and type 1 diabetes mellitus.